Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition ...

A popular obesity drug may help treat a dangerous ... in the weight loss drug Zepbound and also the diabetes treatment Mounjaro, appeared to reduce the severity of sleep apnea along with reducing ...

A popular weight loss drug may be able to assist in the treatment ... to expand the use of the drug to be able to treat moderate to severe sleep apnea and a decision could come by the end of ...

The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive sleep apnea. The Food and Drug Administration on Friday authorized the use of Zepbound ...

The Food and Drug Administration ... Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved to treat patients ...

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, marking the ...

Zepbound is the first prescription drug approved specifically to treat the common ... been prescribing weight loss drugs to people with sleep apnea. The F.D.A.’s decision may place added ...

The Food and Drug Administration on Friday approved the weight-loss drug Zepbound to treat obstructive ... drugs to people with sleep apnea. The FDA’s decision may place added pressure on ...

Dec. 21 (UPI) --Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for treating moderate to severe obstructive sleep apnea.